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Abstract
Background: To compare the microRNA (miRNA) expression profiles in neurons and innervated muscles after
sciatic nerve entrapment using a non-constrictive silastic tube, subsequent surgical decompression, and
denervation injury.
Methods: The experimental L4-L6 spinal segments, dorsal root ganglia (DRGs), and soleus muscles from each
experimental group (sham control, denervation, entrapment, and decompression) were analyzed using an Agilent
rat miRNA array to detect dysregulated miRNAs. In addition, muscle-specific miRNAs (miR-1, -133a, and -206) and
selectively upregulated miRNAs were subsequently quantified using real-time reverse transcription-polymerase
chain reaction (real-time RT-PCR).
Results: In the soleus muscles, 37 of the 47 miRNAs (13.4% of the 350 unique miRNAs tested) that were
significantly downregulated after 6 months of entrapment neuropathy were also among the 40 miRNAs (11.4% of
the 350 unique miRNAs tested) that were downregulated after 3 months of decompression. No miRNA was
upregulated in both groups. In contrast, only 3 miRNAs were upregulated and 3 miRNAs were downregulated in
the denervated muscle after 6 months. In the DRGs, 6 miRNAs in the entrapment group (miR-9, miR-320, miR-324-
3p, miR-672, miR-466b, and miR-144) and 3 miRNAs in the decompression group (miR-9, miR-320, and miR-324-3p)
were significantly downregulated. No miRNA was upregulated in both groups. We detected 1 downregulated
miRNA (miR-144) and 1 upregulated miRNA (miR-21) after sciatic nerve denervation. We were able to separate the
muscle or DRG samples into denervation or entrapment neuropathy by performing unsupervised hierarchal
clustering analysis. Regarding the muscle-specific miRNAs, real-time RT-PCR analysis revealed an ~50% decrease in
miR-1 and miR-133a expression levels at 3 and 6 months after entrapment, whereas miR-1 and miR-133a levels
were unchanged and were decreased after decompression at 1 and 3 months. In contrast, there were no statistical
differences in the expression of miR-206 during nerve entrapment and after decompression. The expression of
muscle-specific miRNAs in entrapment neuropathy is different from our previous observations in sciatic nerve
denervation injury.
Conclusions: This study revealed the different involvement of miRNAs in neurons and innervated muscles after
entrapment neuropathy and denervation injury, and implied that epigenetic regulation is different in these two
conditions.
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Chronic nerve compression affects millions of indivi-
duals and results in pain and loss of function. Depen-
dent on the amount and duration of compression
imposed on the nerve, the pathological changes asso-
ciated with chronic nerve compression range from the
breakdown of the blood-nerve barrier in the early stages,
to subperineurial edema, fibrosis, demyelination, and
eventually Wallerian degeneration, which can be asso-
ciated with loss of two-point discrimination and muscle
atrophy [1,2]. Surgical decompression of the nerve is
warranted if the symptoms are refractory to conservative
treatments; however, the reversal of motor weakness is
usually limited and unpredictable [1]. Generally, dener-
vation leads to significant changes in the innervated
muscle, e.g., muscle atrophy. In contrast, reinnervation
helps to reverse the change or to prevent further dete-
rioration of the denervated muscle [3]. After nerve
injury, the mismatch of the motor and sensory fibers of
the mixed nerve in nerve microanastomosis, the exis-
tence of a long nerve defect, and a long distance from
the injured area to the innervated muscle are considered
to be the main factors leading to a worse functional out-
come [4]. In entrapment neuropathy, considering that
there are no aforementioned circumstances, it is
unknown why a successful surgical decompression does
not result in a predictable and satisfactory outcome;
therefore, a better understanding of the mechanisms of
induction and mediation of these conditioning responses
is necessary.
MicroRNAs (miRNAs) are emerging as key modula-
tors of post-transcriptional gene regulation in a variety
of tissues, including the nervous system [5]. miRNAs are
a novel regulatory class of non-coding, single-stranded
RNAs of approximately 22 nucleotides that are impli-
cated in a wide range of diverse genetic regulatory
mechanisms [6,7]. Basic and clinical studies suggested
that miRNAs are important regulators in normal physio-
logical processes and diseases [8-11]. Many miRNAs are
expressed in a tissue-specific manner. In neurons, miR-
NAs are expressed at all stages of development, and
miRNA-dependent posttranscriptional gene regulation
plays a pivotal role at all stages of neural development,
including neural differentiation, morphogenesis, and
plasticity [12]. Recent results also point to a role for
miRNAs in axonal biology [13] as well as in the control
of synaptic function and plasticity [5]. In addition, there
is increasing evidence for the involvement of micro-
RNAs in myopathies [14-16]. A number of microRNAs,
including muscle-specific and non-muscle-specific miR-
NAs, have been characterized as regulators of skeletal
muscle development and diseases [17-20] as well as of
skeletal muscle remodeling [21]. Three muscle-specific
miRNAs (miR-1, miR-133, and miR-206), with multiple
key roles in the control of muscle growth and differen-
tiation, have been the focus of intense research. We pre-
viously demonstrated that the expression of miR-1 and
miR-133 in the soleus muscle of rats increased by ~2-
fold at 4 months after sciatic nerve denervation and
after reinnervation with microanastomosis [22]; how-
ever, the expression of miR-206 was significantly
increased by 3-fold at 1 month later and lasted for at
least 4 months after reinnervation, but not after dener-
vation [22]. Moreover, the expression of miR-206 may
play a role in determining fiber type after peripheral
nerve regeneration via the downregulation of the Mef2
transcript [22]. It was suggested that the increased
expression of miR-206 in newly formed myotubes may
reflect active regeneration and efficient maturation of
skeletal muscle fibers [23]. In a mouse model of the
neurodegenerative disease amyotrophic lateral sclerosis
(ALS), the role of miR-206 in the reinnervation of the
neuromuscular junction after injury and in improving
survival was also defined [24].
Given the importance of miRNAs, we were interested
in the expression profile of miRNAs involved in entrap-
ment neuropathy. We addressed this issue using a
microarray-based screening approach in the neurons
and innervated muscles involved in this condition, and
compared the data with the expression patterns
observed in denervation injury and after decompression
surgery. In addition, the expression profiles of the upre-
gulated neuron- and muscle-specific miRNAs in the
soleus muscle were investigated using real-time reverse
transcription-polymerase chain reaction (real-time RT-
PCR).
Methods
Animal surgery and tissue preparation
The experiments were performed on adult male Spra-
gue-Dawley rats weighing 250-300 g. The experimental
rats were randomly grouped into sham control, denerva-
tion, entrapment, or decompression, with 6 rats for each
indicated evaluation time point. The rats were anesthe-
tized using an intraperitoneal injection of 400 mg/kg
chloral hydrate. The sciatic nerves were exposed at the
mid-thigh level after a dorsolateral skin incision had
been made and the fascia had been split between the
gluteus and biceps femoris muscles. The right sciatic
nerve was gently dissected from the surrounding con-
nective tissues from the gluteus muscle to the trifurca-
tion of the sciatic nerve. In the denervation group, the
sciatic nerve was severed at 1 cm proximal to the nerve
trifurcation, which innervates all lower leg muscles
including the soleus muscle, and we surgically removed
a 1-cm segment of the proximal nerve. The proximal
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transferred cephalically into the proximal thigh muscle
to prevent regenerative terminal or spontaneous collat-
eral sprouting. In the entrapment group, a 1-cm piece
of non-constrictive silastic tube (Baxter Healthcare,
Deerfield, IL, USA) with an inner diameter of 1.3 mm
and an outer diameter of 2.0 mm was placed around the
segment of the sciatic nerve just distal to the gluteus
muscle, as previously reported [25]. In the group of rats
that underwent surgical decompression at 6 months
after the placement of the silastic tube, atraumatic
removal of the silastic tube was performed under opera-
tive microscopy using the same operative and anesthesia
techniques described above [25]. Using this entrapment/
decompression model, we previously demonstrated the
myopathy in a histopathological picture during nerve
entrapment and observed some recovery of myopathy
after surgical decompression [26]. The rats were sacri-
ficed postoperatively at the indicated time points to col-
lect the L4-L6 spinal hemi-segment, ipsilateral dorsal
root ganglia (DRGs), and soleus muscle of the experi-
mental limb. All operations were performed under an
o p e r a t i v em i c r o s c o p eb yt h es a m es u r g e o n .T h es p e c i -
mens were placed in isopentane, frozen in liquid nitro-
g e n ,a n ds t o r e da t- 8 0 ° C .A l lh o u s i n gc o n d i t i o n s ,
surgical procedures, analgesia, and assessments were
performed according to the Animal Care Guidelines and
protocols approved by the Animal Care Committee at
Chang Gung Memorial Hospital.
RNA isolation
Total RNA was extracted using the mirVana miRNA
Isolation Kit (Ambion, Austin, TX, USA). The purified
RNA was quantified by determining the absorbance at
260 nm using an SSP-3000 Nanodrop spectrophot-
ometer (Infinigen Biotechnology Inc., City of Industry,
CA, USA). For the miRNA array and whole genome
expression analyses, the quality of the purified RNA was
assessed using a Bioanalyzer 2100 (Agilent Technology,
Santa Clara, CA, USA). Total RNA (2 μg) was reverse
transcribed into cDNA in a total volume of 20 μLu s i n g
the High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, Foster City, CA, USA). Each
miRNA cDNA (10 ng) was obtained using the TaqMan
miRNA Reverse Transcription Kit (Applied Biosystems)
with the miRNA being reverse transcribed from the tar-
get miRNA using sequence-specific stem-loop primers.
Expression of miRNAs
The experimental spinal segments, DRGs, and muscles
from 3 rats in each group (sham control, denervation,
entrapment, and decompression) were used for the
microarray analyses. In brief, 100 ng of total RNA was
dephosphorylated using 11.2 units of calf intestine
alkaline phosphatase (GE Healthcare Life Sciences,
Uppsala, Sweden) for 30 min at 37°C. The reaction was
terminated by heating the samples at 100°C for 5 min
and immediate cooling to 0°C. Dimethyl sulfoxide
(DMSO, 5 μL) was then added; the solution was heated
to 100°C for 5 min and immediately cooled to 0°C.
Ligase buffer and bovine serum albumin (BSA) were
added and ligation was performed by adding pCp-Cy3
(50 μM) and 15 units T4 RNA ligase in 28 μL. The sam-
ples were then incubated at 16°C for 2 h. The labeled
miRNAs were desalted using MicroBioSpin6 columns
(Bio-Rad, Hercules, CA, USA). Subsequently, 2× hybridi-
zation buffer was added to the labeled mixture to a final
volume of 45 μL. The mixture was heated for 5 min at
100°C and immediately cooled to 0°C. Each 45-μls a m -
ple was hybridized to an Agilent Rat miRNA Array
(G4473A) at 55°C for 20 h; this array includes 350 rat
miRNAs based on the Sanger miRBase (release 10.1).
After hybridization, the slides were washed at room
temperature for 5 min in Gene Expression Wash Buffer
1 and then for 5 min in Gene Expression Wash Buffer
2. The slides were scanned on an Agilent microarray
scanner G2565A at 100% and 5% sensitivity settings.
Agilent Feature Extraction software (version 9.5.3) was
used for image analysis, and normalization software was
used to quantify the signal and background intensity for
each feature. The substantially normalized data were
analyzed using the rank-consistency filtering LOWESS
method. The microarray data were analyzed using Gene-
Spring GX 7.3.1 software (Agilent Technologies). We
selected those differentially expressed miRNA genes that
showed a 2-fold change in their expression level
between the experimental specimens and the sham con-
trol group. These differentially expressed genes were
applied to hierarchical cluster analysis using average
linkage and Pearson correlation as a measure of similar-
ity. The miRNA array data have been deposited in the
Gene Expression Omnibus (accession number [GEO:
GSE22181])
Quantification of miRNA expression
miRNA expression was quantified using real-time RT-
PCR on the Applied Biosystems 7500 Real-Time PCR
System (Applied Biosystems) to verify the upregulated
miRNA targets detected by the miRNA array from the
spinal segments (miR-384-3p, miR-325-5p, miR-342-5p,
and miR-340-5p) and DRGs (miR-21) in the denervation
and sham control groups, and the muscle-specific miR-
NAs (miR-1, miR-133a, and miR-206) in the soleus
muscles of the sham control, entrapment, and decom-
pression groups. The expression of each miRNA was
represented relative to the expression of the small RNA
4.5 S internal control. We calculated the fold-expression
of induction as the relative expression value obtained
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group. The comparison between the groups included
ANOVA and an appropriate post hoc test to compen-
sate for multiple comparisons (SigmaStat; Jandel, San
Rafael, CA, USA). P-values < 0.05 were considered
significant.
In situ hybridization
We used in situ hybridization to localize miR-21 expres-
sion in the DRG sections. The frozen section specimens
were acquired from 10-μm thick transverse cross sec-
tions from the middle of each fresh specimen using a
cryostat (Cryostat Leica CM3050, Bannockburn, IL,
USA). Cryosections were fixed in 4% paraformaldehyde,
acetylated in 0.1 M triethanolamine (pH 8.0), and
then treated with proteinase K. After washing with
phosphate-buffered saline (PBS), the specimens were
incubated with 10 pmol of locked nucleic acid (LNA)-
modified oligonucleotide probe (Exiqon, Woburn, MA,
USA) complementary to Rattus norvegicus (rno)-miR-21
and labeled with digoxigenin (DIG) at 50°C overnight.
For the sham control experiment, the tissue sections
were hybridized with rno-U6 probes or without rno-
miR-21 probes as positive or negative controls, respec-
tively. After hybridization, the slides were washed in
50% formamide, 1× saline sodium citrate (SSC), and
0.1% Tween-20 at 50°C, followed by washes in 0.2× SCC
and PBS at room temperature. The specimens were
then incubated with the blocking solution followed by a
horseradish peroxidase (HRP)-conjugated anti-DIG anti-
body. The signal was enhanced using the TSA Plus
DNP HRP system (PerkinElmer Life Sciences, Boston,
MA, USA). The hybridized probes were detected and
visualized by a color reaction with 3,3’-diaminobenzidine
(DAB).
Results
Expression profile of the miRNAs in the muscle
miRNA array analysis indicated that approximately
13.4% (n = 47) and 11.4% (n = 40) of all rat miRNAs
tested (350 unique miRNAs) were significantly
decreased at 6 months of entrapment neuropathy and at
3 months after decompression, respectively, in the
soleus muscle (Additional file 1: Table S1). Notably,
there were 37 overlapping miRNAs under these 2 condi-
tions and no miRNAs were upregulated in the soleus
muscles of these 2 groups. Surgical decompression
appeared to not remarkably alter the general expression
of the downregulated miRNAs in the innervated muscle
in entrapment neuropathy. In contrast, 3 miRNAs (miR-
499, miR-1, miR-133a, and miR-466b) were upregulated
in the denervated muscle and 3 miRNAs (miR-329,
miR-204, and miR-139-3p) were downregulated after
6 months. A hierarchical cluster analysis of all
significantly dysregulated miRNAs is shown in Figure 1,
illustrative of miRNAs differentially expressed under
t h e s e3c o n d i t i o n s .W ew e r ea b l et os e p a r a t et h es a m -
ples into denervation, entrapment, and decompression
by performing unsupervised hierarchal clustering
analysis.
miRNA expression profiles in the neurons
In the DRGs, 6 miRNAs (miR-9, miR-320, miR-324-3p,
miR-672, miR-466b, and miR-144) were significantly
downregulated in the entrapment group and 3 miRNAs
(miR-9, miR-320, and miR-324-3p) were significantly
downregulated in the decompression group. Although
there also appeared to be a decrease of miR-672, miR-
466b, and miR-144 in the decompression group, it was
not statistically significant in all 3 specimens. No miR-
NAs were upregulated in the DRGs of the entrapment
and decompression groups. On the other hand, after scia-
tic nerve denervation, we observed 1 downregulated
miRNA (miR-144) and 1 upregulated miRNA (miR-21)
in the DRGs (Figure 1). To localize the expression of
miR-21 in the DRGs, in situ hybridization of miR-21 was
performed to differentiate whether the upregulation
occurred in the neurons or the interstitial connective
tissue. As shown in Figure 2, in comparison with the
negative control (Figure 2A), the positive control probe
rno-U6 was abundantly and diffusely expressed in the
perinuclear region of the DRG neurons after 6 months of
denervation (Figure 2B). In addition, using DIG-labeled
miR-21 probes, intense signals for miR-21 were also
observed in the perinuclear region of the neurons (Figure
2C). Real time RT-PCR revealed that the expression of
miR-21 in the DRGs was detected after 1 week of dener-
vation with an ~6-fold increase that lasted for up to
6 months (Figure 2D). We were able to separate the sam-
ples into denervation, entrapment, and decompression by
performing unsupervised hierarchal clustering analysis.
In the L4-L6 spinal segments, no dysregulated miR-
NAs were detected using the miRNA array in the
entrapment and decompression groups. In the denerva-
tion group, 4 miRNAs (miR-384-3p, miR-325-5p, miR-
342-5p, and miR-340-5p) were significantly upregulated,
but no miRNA was downregulated in the spinal segment
specimens after 6 months. However, using quantitative
real-time RT-PCR to independently measure the relative
expression of these 4 selected miRNAs in the spinal seg-
ment samples, none of them could be validated and all
miRNAs were upregulated.
Expression of muscle-specific miRNAs in the entrapment
and decompression groups
After nerve entrapment using a silastic tube, we
observed the downregulation of miR-1 and miR-133a in
the soleus muscle at 3 months after its insertion that
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Page 4 of 9Figure 1 Hierarchical cluster analysis. Using a hierarchical method, a clustering graph was created from those miRNAs with increased (red) or
decreased (blue) fold of expression from 3 soleus muscles (left graph) and dorsal root ganglia (right graph) in the group of rats that sustained
denervation for 6 months, entrapment for 6 months, or decompression for 3 months against those from the sham control group.
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Page 5 of 9Figure 2 In situ hybridization analysis. In comparison with the negative control (Figure 2A), in situ hybridization analysis revealed that the
positive control probe rno-U6 was abundantly and diffusely expressed in the perinuclear region of the neurons in the denervated dorsal root
ganglia (DRGs) (Figure 2B). Intense signals for miR-21 in the perinuclear region of the neurons were also observed in the tissue sections at 1
month after denervation injury by using digoxigenin-labeled miR-21 probes (Figure 2C). Real time RT-PCR revealed that the expression of miR-21
in the DRGs was increased by ~6 fold; it was detected 1 week after denervation and lasted for up to 6 months (Figure 2D). Bars represent
means ± standard error of 6 independent experiments; *, P < 0.05 vs. sham control.
Figure 3 Expression of muscle-specific miRNAs using quantitative real-time PCR. After entrapment, the expression of miR-1 and miR-133
was significantly decreased to ~50% of those observed in the sham control group at 3 and 6 months after entrapment. After decompression,
miR-1 and miR-133a levels were unchanged and sustained a significant decrease at 1 and 3 months later, respectively. There were no statistical
differences in the expression of miR-206 at the indicated time points after nerve entrapment and after decompression. Bars represent means ±
standard error of 6 independent experiments; *, P < 0.05 vs. sham control.
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Real-time RT-PCR analysis revealed an ~50% decrease
in the expression levels of miR-1 and miR-133a at 3 and
6 months after entrapment, whereas the levels of miR-1
and miR-133a were unchanged and then decreased after
decompression for 1 and 3 months, respectively. The
expression patterns of miR-1 and miR-133a were similar
after entrapment and decompression. In contrast, there
were no statistical differences in the expression of miR-
206 after entrapment and decompression.
Discussion
According to the degrees of nerve injury defined on the
basis of the histopathology and pathophysiology of nerve
injury [27], entrapment neuropathy would be graded as
a grade II or III injury [28], but not as a grade V injury
after nerve transection (neurotmesis). Electron micro-
scopic analysis of axonal integrity in entrapment neuro-
pathy has also shown no morphometric evidence of
axonal injury [28,29]. Therefore, it is not surprising that
neurons and innervated muscles exhibit different
responses between entrapment neuropathy and denerva-
tion injury. In this study, we demonstrated that entrap-
ment neuropathy resulted in miRNA expression
patterns that differed from those in denervation injury
in the DRGs and the innervated soleus muscle. Com-
pared to the 3 upregulated and the 3 downregulated
miRNAs in the denervated muscle, we observed more
extensively downregulated miRNAs (13.4%, 47 of the
350 rat miRNAs) in entrapment neuropathy. In the
DRGs, there was 1 downregulated and 1 upregulated
miRNA after nerve denervation, but there were 6 signifi-
cantly downregulated miRNAs after entrapment neuro-
pathy. We were able to separate the DRGs or muscle
samples into denervation or entrapment neuropathy by
performing unsupervised hierarchal clustering analysis.
Considering that a single miRNA may target multiple
transcripts [30] or activate an extremely powerful
mechanism to dynamically adjust the cell’s protein con-
tent and influence cellular physiology [31,32], it is rea-
sonable to assume that, despite the fact that there are
still unknown downstream target genes and functions,
the epigenetic regulation of neurons and innervated
muscle is different in response to entrapment neuropa-
thy and denervation injury.
Moreover, the expression of muscle-specific miRNAs
was different between entrapment neuropathy and
denervation injury. Previously, in a rat model of sciatic
nerve denervation, in the absence or presence of nerve
microanastomosis [22], we demonstrated that the
expression patterns of miR-1 and miR-133a were similar
in the soleus muscle after denervation and reinnerva-
tion. The expression of miR-1 and miR-133a increased
in the muscle after 4 months of denervation and
reinnervation. On the other hand, the expression of
miR-206 was only significantly increased at 1 month
after reinnervation, but not after denervation, and lasted
for at least 4 months. In this study, there was an ~50%
decrease in the expression levels of miR-1 and miR-133a
at 3 and 6 months after entrapment as well as after 1
and 3 months of decompression. In contrast, we found
no statistical difference in the expression of miR-206
during nerve entrapment or after decompression. miR-1
and miR-133a are transcribed from a common pre-
miRNA precursor in the miR-1/miR-133a locus that
generates different primary transcripts [33]. Thus, it is
not surprising to discover that the expression patterns
of miR-1 and miR-133a were similar. In contrast, the
expression pattern of miR-206 was found to be indepen-
dent from those of miR-1 and miR-133a. However, the
expression response of these 3 muscle-specific miRNAs
to entrapment neuropathy and denervation injury was
different. It has been reported that the expression of
miR-1 and miR-133a decreased during skeletal muscle
hypertrophy after 7 days of functional overload in rats.
The decreased expression of miR-1 and miR-133a was
suggested to compensate for the overload by removing
the posttranscriptional repression of the necessary target
genes [34]. In addition, miR-206 is required for the effi-
cient regeneration of neuromuscular synapses after
acute nerve injury [35]. At 3 weeks after surgical dener-
vation, the reinnervation of the denervated muscles by
motor axons was delayed in miR-206
-/- mice, but wild-
type and miR-206
-/- mice exhibited similar degrees of
muscle atrophy [35]. However ,t h er o l eo ft h em u s c l e -
specific miRNAs to entrapment neuropathy or denerva-
tion injury remains to be investigated.
We also demonstrated that, after decompression, the
miRNA expression patterns in the soleus muscles were
similar to those in entrapment neuropathy. Although we
were able to separate the muscle or DRGs samples into
entrapment or decompression by performing unsuper-
vised hierarchal clustering analysis, 37 of the 47 miR-
NAs downregulated in entrapment neuropathy were
among the 40 miRNAs downregulated after decompres-
sion; besides, the expression profile of muscle-specific
miRNAs was not different after entrapment neuropathy
or decompression. Surgical decompression appeared to
not remarkably alter the general expression of the
downregulated miRNAs in the muscle during entrap-
ment neuropathy, leading us speculate that is it possible
that the unaltered posttranscriptional regulation attri-
butes to some refractory response of the muscle after
surgical decompression. The identification of the target
genes of the differentially expressed miRNAs using a
combined approach of an miRNA prediction algorithm
and whole genome expression analysis under the condi-
tion of gain-of-function or loss-of function of each
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miRNA. However, considering the lack of transgenic or
knock-out rodents and the expensive nature of antisense
oligonucleotides or miRNA inhibitors, this goal could
not be easily achieved and requires further extensive
investigation.
In this study, we had demonstrated an ~6-fold
increase in the expression of miR-21 in DRG neurons at
1 week after denervation that lasted for up to 6 months.
miR-21 is one of the most prominent miRNAs impli-
cated in human malignancies [36]. It is highly expressed
i ng l i o b l a s t o m a sa n df u n c t i o n sa sa no n c o g e n i ca n d
anti-apoptotic factor, while it is expressed at basal levels
in other brain tumors and in the normal brain [37,38].
miR-21 was reported to play a cytoprotective role
against injury via its target genes [39,40]; however, the
role and target genes of miR-21 expression in the DRGs
after denervation were beyond the scope of this study.
Besides, we did not detect dysregulated miRNAs in the
L4-L6 spinal segments of the entrapment and decom-
pression groups using miRNA arrays. Although 4 miR-
NAs were significantly upregulated in the miRNA array
experiment, their increased expression could not be vali-
dated using quantitative real-time RT-PCR. It should be
noted that false positive and false negative targets are
expected when using an miRNA array. In a comparison
of six microarray platforms and one next-generation
sequencing machine to detect the differential expression
of miRNAs, Agilent, Ambion, and Exiqon microarrays
had the highest rates of true differentially expressed
calls with true positive/true negative rates of: Agilent,
0.90/0.86; Ambion, 0.91/0.91; and Exiqon, 0.82/0.85
[41]. Generally, quantitative real-time RT-PCR results
are consistent with the results of the high-throughput
microarray method in normal physiological or disease-
related pathological conditions [42,43]; with few identi-
fied targets, microarray and next-generation sequencing
data are regularly validated using quantitative real-time
RT-PCR. Nevertheless, in a genomic miRNA analysis,
microarrays are still the best choice for a standardized
genome-wide assay that is amenable to high-throughput
applications [41]. In addition, we speculated that the
complex composition of the spinal segment tissue,
which contains different neuronal and glial cells and dif-
ferent cells in the supporting connective tissue, may be
the principal obstacle for a correct tissue dissection and
subsequent quantification of miRNA expression. For
these reasons, the interpretation of data acquired from
microarray platforms needs to be carefully performed in
specimens with complex components. In addition,
further experiments on the tissues or neurons acquired
with a more accurate method would be helpful to iden-
tify the miRNA expression profiles in the spinal
segments.
Conclusions
In the past few years, it has become clear that miRNAs
are a fundamental part of coordinated gene regulation
in different aspects of cell biology. This study has pro-
vided new insights into the role of miRNAs after sciatic
nerve denervation, entrapment neuropathy, and decom-
pression by demonstrating the differential regulation of
miRNAs in the innervated neurons and muscles. How-
ever, the field of miRNA research is still in its infancy
and requires further exploration to understand the role
of miRNAs in these conditions. Further identification of
their target genes and their function would help to elu-
cidate the role of each miRNA involved.
Additional material
Additional file 1: Table 1. Dysregulated miRNAs in the soleus muscle of
rats in the denervation injury, entrapment neuropathy, and surgical
decompression groups. † indicates the same miRNA target in the
entrapment and decompression groups.
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